The Press Office provides journalists with information on the diverse range of subjects that are relevant to the pharmaceutical industry. Our role is to ensure that any type of media is able to have access to the industry perspective and opinion.
The UK life sciences industry is facing a major skills shortage which threatens to undermine the research and development of new medicines in the UK and prevent growth and investment in this vital sector. Read more
Dear Mr Osborne,
Ahead of the forthcoming Comprehensive Spending Review I am sure you will have received many letters from across the science community calling for continued public investment in the sector.Read more
Alison Clough, ABPI acting CEO, comments on the delays to the reform of the Cancer Drugs Fund.Read more
Over 100 MPs and Peers are expected to attend today’s Westminster Flu Day, a flu vaccine clinic held in the House of Commons, to encourage their constituents to get this season’s flu vaccine in line with Government recommendations. Parliamentarians who are not be eligible for a free seasonal flu vaccination on the NHS will make a £10 donation to the Carers Trust. £10 is equivalent to the cost of a private vaccination.Read more
The majority of doctors, nurses, hospital specialists and pharmacists believe that payments received by healthcare professionals (HCPs) from pharmaceutical companies should be transparent, according to a survey by leading research consultancy ComRes.Read more
ABPI responds to the new Innovation Scorecard which shows once again unacceptably wide variation in the uptake of NICE-approved medicines in EnglandRead more
Guidance has been published to support charities and pharmaceutical companies in working together to improve the lives of patients.
National Voices and the Association of the British Pharmaceutical Industry have jointly produced a guide on collaboration for both charities and pharmaceutical companies. The guide highlights the benefits that working together can deliver, alongside some of the issues and risks that all parties need to consider. Read more
The Association of the British Pharmaceutical Industry (ABPI), the UK BioIndustry Association (BIA) and the British Generic Manufacturers Association (BGMA) have joined forces to welcome NHS England’s new publication “What is a biosimilar medicine?”.Read more
Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), responds to recent reports in the media on the price of medicines in the UK.Read more
On 17 September 2015, the Association of the British Pharmaceutical Industry (ABPI), in partnership with the Academy of Medical Sciences, held a workshop on ‘real world evidence.’Read more